Ani Pharmaceuticals (ANIP) Return on Equity [ROE] (2011 - 2026)
Ani Pharmaceuticals (ANIP) reported Return on Equity [ROE] of 18.68% for Q2 2026, up 21.08 percentage points from -2.39% a year earlier and up 1.98 percentage points from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Ani Pharmaceuticals posted Return on Equity [ROE] of 16.59%, up 21.02 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +27.63 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -4.43% in FY2024 (-9.46 pp), 5.03% in FY2023 (+19.82 pp), -14.79% in FY2022 (+1.30 pp) and -16.09% in FY2021 (-5.05 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q3 2015.
- Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +4.68 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2023 (a gain of 24.90 percentage points); the low point was Q1 2025 (a drop of 13.15 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 16.71% (Q1 2026), 14.97% (Q4 2025) and 8.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Ani Pharmaceuticals | 1.72 Bn | 502.13 Mn | 165.89 Mn | 18.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.68% |
| Mar 31, 2026 | 16.71% |
| Dec 31, 2025 | 14.97% |
| Sep 30, 2025 | 8.60% |
| Jun 30, 2025 | -2.39% |
| Mar 31, 2025 | -5.12% |
| Dec 31, 2024 | -4.58% |
| Sep 30, 2024 | -1.65% |
| Jun 30, 2024 | 5.95% |
| Mar 31, 2024 | 8.03% |
| Dec 31, 2023 | 4.36% |
| Sep 30, 2023 | 3.19% |
| Jun 30, 2023 | -1.42% |
| Mar 31, 2023 | -8.37% |
| Dec 31, 2022 | -15.31% |
| Sep 30, 2022 | -21.72% |
| Jun 30, 2022 | -20.08% |
| Mar 31, 2022 | -19.18% |
| Dec 31, 2021 | -16.22% |
| Sep 30, 2021 | -11.53% |
API Access
Ani Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();